These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 36182877)

  • 1. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: A trigger of autoimmune diseases.
    Zebardast A; Hasanzadeh A; Ebrahimian Shiadeh SA; Tourani M; Yahyapour Y
    Cell Biol Int; 2023 May; 47(5):848-858. PubMed ID: 36740221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo lupus nephritis after SARS-CoV-2 infection.
    Mok CC; Chu CS; Tse SM
    Lupus; 2023 Jun; 32(7):893-899. PubMed ID: 37173871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune liver diseases and SARS-CoV-2.
    Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
    World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset autoimmune phenomena post-COVID-19 vaccination.
    Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
    Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies.
    Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K
    Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of autoimmunity induced by SARS-CoV-2 and development of post-vaccination autoimmune diseases].
    Montaño-Armendáriz N; Zamudio-Cuevas Y; Fernández-Torres J; Martínez-Flores K; Luján-Juárez IA
    Rev Alerg Mex; 2023 Jan; 69(2):78-88. PubMed ID: 36928248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry and autoimmunity in the time of COVID-19.
    Rojas M; Herrán M; Ramírez-Santana C; Leung PSC; Anaya JM; Ridgway WM; Gershwin ME
    J Autoimmun; 2023 Sep; 139():103070. PubMed ID: 37390745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
    Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
    Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological Facet and Inception after Post-COVID-19 Vaccination.
    Ray SK; Mukherjee S
    Infect Disord Drug Targets; 2023; 23(5):e060423215496. PubMed ID: 37038664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation.
    Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK
    Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
    Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
    Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.